Novalgin and Quinone poisoning - a phase IV clinical study of FDA data
We study 8,702 people who take Novalgin or have Quinone poisoning. No report of Quinone poisoning is found in people who take Novalgin.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Novalgin?
Novalgin has active ingredients of metamizole. It is often used in pain. eHealthMe is studying from 8,699 Novalgin users for its effectiveness, alternative drugs and more.
What is Quinone Poisoning?
Quinone poisoning: no further information found.
Do you take Novalgin and have Quinone poisoning?Check whether Quinone poisoning is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Quinone poisoning and when was it recovered:
Expand to all the drugs that have ingredients of metamizole:
Alternative drugs to, pros and cons of Novalgin:
- Novalgin (8,699 reports)
Quinone poisoning treatments and more:
- Quinone poisoning (3 reports)
COVID vaccines that are related to Quinone poisoning:
- Quinone poisoning in Moderna COVID Vaccine
- Quinone poisoning in Pfizer BioNTech Covid Vaccine
- Quinone poisoning in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Quinone poisoning:
All the conditions that are associated with Quinone poisoning:
How the study uses the data?
The study uses data from the FDA. It is based on metamizole (the active ingredients of Novalgin) and Novalgin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Chlorthalidone and Zejula drug interaction - a second ago
- Infectious Pleural Effusion and johnson and johnson covid vaccine - a second ago
- Luvox and Autonomic Nervous System Imbalance - 2 seconds ago
- Clozapine and White Blood Cell Count Increased - 2 seconds ago
- Rapamune and Ischaemic Cardiomyopathy - 4 seconds ago
- Azelastine Hydrochloride vs. Veramyst - 5 seconds ago
- Hyponatraemia Aggravated and Pre-Eclampsia - 9 seconds ago
- Detrol La and Adhesion - 12 seconds ago
- Pantoprazole and Dry Mouth - 31 seconds ago
- Tacrolimus and Withdrawal Syndrome - 39 seconds ago